throbber
UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`BAUSCH HEALTH COMPANIES INC. AND
`BAUSCH HEALTH US LLC
`Petitioners
`
`v.
`
`FLOW PHARMA INC.,
`Patent Owner.
`
`Case No. IPR2020-00165
`Patent 8,138,157
`
`JOINT MOTION TO TERMINATE PROCEEDING PURSUANT TO 35
`U.S.C. 317(a) AND 37 C.F.R. §§ 42.72 AND 42.74
`
`

`

`Pursuant to 35 U.S.C. § 317(a), 37 C.F.R. §§ 42.72 and 42.74, and the Board’s
`
`authorization on September 1, 2020, Patent Owner Flow Pharma Inc. and Petitioners
`
`Bausch Health Companies Inc. and Bausch Health U.S., LLC (collectively, “the
`
`Parties”) jointly request termination of IPR2020-00165 regarding U.S. Patent No.
`
`8,138,157 (“the ’157 patent”).
`
`The Parties have settled their disputes involving the ’157 patent. They have
`
`agreed to settle the claims related to the ’157 patent in the related district court
`
`litigation (Flow Pharma, Inc. v. Bausch Health Companies Inc. et al., Case No. 4:18-
`
`cv-05769-JST (N.D.Cal.)). The Parties have filed a stipulation to dismiss the
`
`district court litigation with prejudice. The Parties are not aware of additional
`
`proceedings regarding the ’157 patent.
`
` The Parties are concurrently filing a true and correct copy of their written
`
`Settlement Agreement in connection with this matter, as required by statute, as
`
`Confidential Exhibit 1042. The Parties jointly certify that, aside from the
`
`Settlement Agreement, there are no other agreements or understandings, oral or
`
`written, between the Parties, including any collateral agreements or understandings,
`
`made in connection with, or in contemplation of, the termination of the present
`
`proceeding. A joint request to treat the Settlement Agreement as business
`
`2
`
`

`

`confidential information kept separate from the file of the involved patent pursuant
`
`to 35 U.S.C. § 317(b) and 37 C.F.R. §42.74(c) is being filed concurrently.
`
`I.
`
`Legal Standard
`
`An AIA trial proceeding “shall be terminated with respect to any petitioner
`
`upon the joint request of the petitioner and the patent owner, unless the Office has
`
`decided the merits of the proceeding before the request for termination is filed.” 35
`
`U.S.C. § 317(a); § 327(a). A joint motion to terminate generally “must (1) include
`
`a brief explanation as to why termination is appropriate; (2) identify all parties in
`
`any related litigation involving the patents at issue; (3) identify any related
`
`proceedings currently before the Office, and (4) discuss specifically the current
`
`status of each such related litigation or proceeding with respect to each party to the
`
`litigation or proceeding.” Heartland Tanning, Inc. v. Sunless, Inc., IPR2014-
`
`00018, Paper No. 26, at *2 (P.T.A.B. July 28, 2014).
`
`II.
`
`Dismissal of District Court Matter and Issuance of Settlement
`Agreement Warrants Termination
`
`Termination of this IPR is appropriate as the Board has not yet decided the
`
`merits of the proceeding, the related litigation between the Parties has been
`
`dismissed with prejudice, and the Parties have agreed that it is appropriate to
`
`terminate this proceeding. “Generally, the Board expects that a proceeding will
`
`terminate after the filing of a settlement agreement.” DTN LLC v. Farms
`
`3
`
`

`

`Technology, LLC, IPR2018-01412, Paper No. 21 (June 14, 2019) (precedential).
`
`Terminating this proceeding promotes the Congressional goal of establishing a more
`
`efficient and streamlined patent system that, inter alia, limits unnecessary and
`
`counterproductive litigation costs. See Patent Office Trial Practice Guide, 77 Fed.
`
`Reg. 48756, 48768 (Aug. 14, 2012). Given the dismissal with prejudice of the
`
`subject patent from the litigation between the Parties, the absence of any other
`
`pending litigation involving this patent, or any public interest or other factors
`
`militating against termination, termination of this proceeding is justified.
`
`III. Related Proceedings
`
`As stated above, the related district court action between Patent Owner and
`
`Petitioners has been settled.
`
`IV. Conclusion
`
`For the foregoing reasons, Patent Owner and Petitioners jointly request that
`
`the Board terminate IPR2020-00165.
`
`4
`
`

`

`Dated: September 1, 2020
`
`Respectfully submitted,
`
`/s/ Scott K. Reed
`Scott K. Reed (Reg. No. 32,433)
`VENABLE LLP
`1290 Avenue of the Americas, 20th Floor
`New York, NY 10104
`Tel: (212) 218-2227
`
`Counsel for Petitioners,
`Bausch Health Companies Inc. and
`Bausch Health U.S., LLC
`
`___________________
`Karl Bozicevic (Reg. No. 28,807)
`BOZICEVIC, FIELD AND FRANCIS LLP
`201 Redwood Shores Parkway, Suite 200
`Redwood City, CA 94065
`Telephone: (650) 327-3400
`
`Counsel for Patent Owner,
`Flow Pharma Inc.
`
`5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket